Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-03-15

AUTHORS

Zachariah Payne Sellers, Lukasz Bolkun, Janusz Kloczko, Marzena Liliana Wojtaszewska, Krzysztof Lewandowski, Marcin Moniuszko, Mariusz Z. Ratajczak, Gabriela Schneider

ABSTRACT

BACKGROUND: The delta-like non-canonical Notch ligand 1 (DLK1)-maternally expressed 3(MEG3) locus (DLK1-MEG3 locus) plays a critical role in the maintenance and differentiation of hematopoietic stem cells. Accumulating evidence implicates the imprinted genes from this locus, DLK1 and MEG3, in the development and progression of acute myeloid leukemia (AML). However, the contribution of this locus to the treatment response of patients and their survival is unknown. METHODS: DNA methylation of select CG dinucleotide-containing amplicons (CpG sites) within the DLK1-MEG3 locus and within differentially methylated regions of other imprinted loci was assessed in the mononuclear cells of 45 AML patients by combined bisulfite restriction analysis. Methylation results were compared with patient response to first-round induction therapy and overall survival. Multivariable analysis was employed to identify independent prognostic factors for patient overall survival in AML. RESULTS: Increased methylation at CpG sites within the MEG3 promotor region was observed in AML patients having longer overall survival. In addition, patients with shorter overall survival had increased expression of DLK1 and MEG3, and methylation at the MEG3-DMR CpG site inversely correlated with MEG3 expression. Multivariable analysis revealed that methylation at CG9, a non-imprinted CpG site within the MEG3 promotor region which contains a CCCTC-binding factor (CTCF)-binding DNA sequence, is an independent prognostic factor for the overall survival of AML patients. CONCLUSIONS: The results of our pilot study underscore the importance of the DLK1-MEG3 locus in AML development and progression. We identify CG9 methylation as an independent prognostic factor for AML patient survival, which suggests that distinct miRNA signatures from the DLK1-MEG3 locus could reflect varying degrees of cell stemness and present novel opportunities for personalized therapies in the future. These data provide a foundation for future studies into the role of higher-order chromatin structure at DLK1-MEG3 in AML. More... »

PAGES

50

References to SciGraph publications

  • 2017-05-15. Why are hematopoietic stem cells so ‘sexy’? on a search for developmental explanation in LEUKEMIA
  • 2013-07-17. Maternal imprinting at the H19–Igf2 locus maintains adult haematopoietic stem cell quiescence in NATURE
  • 2009-07-30. Novel Epigeneitc Mechanisms that Control Pluripotency and Quiescence of Adult Bone Marrow-Derived Oct4+ Very Small Embryonic Like Stem Cells in LEUKEMIA
  • 2018-07-06. Analysis of the Paternally-Imprinted DLK1–MEG3 and IGF2–H19 Tandem Gene Loci in NT2 Embryonal Carcinoma Cells Identifies DLK1 as a Potential Therapeutic Target in STEM CELL REVIEWS AND REPORTS
  • 2004-04. Birth of parthenogenetic mice that can develop to adulthood in NATURE
  • 2010-04-25. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells in NATURE
  • 2015-02-23. Imprinted genes in myeloid lineage commitment in normal and malignant hematopoiesis in LEUKEMIA
  • 2008-01-06. Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes in NATURE GENETICS
  • 2005-06-16. Dlk1 in normal and abnormal hematopoiesis in LEUKEMIA
  • 2017-04-12. Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways in LEUKEMIA
  • 2012-04-23. Specific small nucleolar RNA expression profiles in acute leukemia in LEUKEMIA
  • 2007-08-19. High-frequency generation of viable mice from engineered bi-maternal embryos in NATURE BIOTECHNOLOGY
  • 2005-04-04. Expression of DLK1 in hematopoietic cells results in inhibition of differentiation and proliferation in ONCOGENE
  • 2018-04-10. H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia in CLINICAL EPIGENETICS
  • 2005-12-08. Allele-specific methylation of a functional CTCF binding site upstream of MEG3 in the human imprinted domain of 14q32 in CHROMOSOME RESEARCH
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/s13148-019-0643-z

    DOI

    http://dx.doi.org/10.1186/s13148-019-0643-z

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1112771414

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/30876483


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Calcium-Binding Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Methylation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Gene Expression Regulation, Neoplastic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genomic Imprinting", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Induction Chemotherapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Leukemia, Myeloid, Acute", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Membrane Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pilot Projects", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Promoter Regions, Genetic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "RNA, Long Noncoding", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Sequence Analysis, DNA", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Survival Analysis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Young Adult", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY USA", 
              "id": "http://www.grid.ac/institutes/grid.266623.5", 
              "name": [
                "Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sellers", 
            "givenName": "Zachariah Payne", 
            "id": "sg:person.01203064236.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203064236.14"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Hematology, Medical University of Bialystok, Bialystok, Poland", 
              "id": "http://www.grid.ac/institutes/grid.48324.39", 
              "name": [
                "Department of Hematology, Medical University of Bialystok, Bialystok, Poland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bolkun", 
            "givenName": "Lukasz", 
            "id": "sg:person.01210213422.61", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210213422.61"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Hematology, Medical University of Bialystok, Bialystok, Poland", 
              "id": "http://www.grid.ac/institutes/grid.48324.39", 
              "name": [
                "Department of Hematology, Medical University of Bialystok, Bialystok, Poland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kloczko", 
            "givenName": "Janusz", 
            "id": "sg:person.0734513303.36", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734513303.36"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Hematology and Bone Marrow Transplantation, University of Medical Sciences, Pozna\u0144, Poland", 
              "id": "http://www.grid.ac/institutes/grid.22254.33", 
              "name": [
                "Department of Hematology and Bone Marrow Transplantation, University of Medical Sciences, Pozna\u0144, Poland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wojtaszewska", 
            "givenName": "Marzena Liliana", 
            "id": "sg:person.0725226540.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725226540.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Hematology and Bone Marrow Transplantation, University of Medical Sciences, Pozna\u0144, Poland", 
              "id": "http://www.grid.ac/institutes/grid.22254.33", 
              "name": [
                "Department of Hematology and Bone Marrow Transplantation, University of Medical Sciences, Pozna\u0144, Poland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lewandowski", 
            "givenName": "Krzysztof", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland", 
              "id": "http://www.grid.ac/institutes/grid.48324.39", 
              "name": [
                "Department of Allergology, Medical University of Bialystok, Bialystok, Poland", 
                "Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Moniuszko", 
            "givenName": "Marcin", 
            "id": "sg:person.01127634326.53", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127634326.53"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Regenerative Medicine, Medical University of Warsaw, Warsaw, Poland", 
              "id": "http://www.grid.ac/institutes/grid.13339.3b", 
              "name": [
                "Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY USA", 
                "Department of Regenerative Medicine, Medical University of Warsaw, Warsaw, Poland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ratajczak", 
            "givenName": "Mariusz Z.", 
            "id": "sg:person.013444343657.96", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013444343657.96"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY USA", 
              "id": "http://www.grid.ac/institutes/grid.266623.5", 
              "name": [
                "Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Schneider", 
            "givenName": "Gabriela", 
            "id": "sg:person.01304531757.79", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304531757.79"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/leu.2009.153", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002488822", 
              "https://doi.org/10.1038/leu.2009.153"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.leu.2403832", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049538565", 
              "https://doi.org/10.1038/sj.leu.2403832"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature09017", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050347178", 
              "https://doi.org/10.1038/nature09017"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10577-005-1015-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002796511", 
              "https://doi.org/10.1007/s10577-005-1015-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature12303", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028161095", 
              "https://doi.org/10.1038/nature12303"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt1331", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012172214", 
              "https://doi.org/10.1038/nbt1331"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/leu.2015.47", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014631957", 
              "https://doi.org/10.1038/leu.2015.47"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/leu.2012.111", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049424250", 
              "https://doi.org/10.1038/leu.2012.111"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/leu.2017.148", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1085414856", 
              "https://doi.org/10.1038/leu.2017.148"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1208637", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011733790", 
              "https://doi.org/10.1038/sj.onc.1208637"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12015-018-9838-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1105315115", 
              "https://doi.org/10.1007/s12015-018-9838-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature02402", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028269094", 
              "https://doi.org/10.1038/nature02402"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ng.2007.56", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000021875", 
              "https://doi.org/10.1038/ng.2007.56"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/leu.2017.116", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1084752577", 
              "https://doi.org/10.1038/leu.2017.116"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13148-018-0486-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1103148817", 
              "https://doi.org/10.1186/s13148-018-0486-z"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2019-03-15", 
        "datePublishedReg": "2019-03-15", 
        "description": "BACKGROUND: The delta-like non-canonical Notch ligand 1 (DLK1)-maternally expressed 3(MEG3) locus (DLK1-MEG3 locus) plays a critical role in the maintenance and differentiation of hematopoietic stem cells. Accumulating evidence implicates the imprinted genes from this locus, DLK1 and MEG3, in the development and progression of acute myeloid leukemia (AML). However, the contribution of this locus to the treatment response of patients and their survival is unknown.\nMETHODS: DNA methylation of select CG dinucleotide-containing amplicons (CpG sites) within the DLK1-MEG3 locus and within differentially methylated regions of other imprinted loci was assessed in the mononuclear cells of 45 AML patients by combined bisulfite restriction analysis. Methylation results were compared with patient response to first-round induction therapy and overall survival. Multivariable analysis was employed to identify independent prognostic factors for patient overall survival in AML.\nRESULTS: Increased methylation at CpG sites within the MEG3 promotor region was observed in AML patients having longer overall survival. In addition, patients with shorter overall survival had increased expression of DLK1 and MEG3, and methylation at the MEG3-DMR CpG site inversely correlated with MEG3 expression. Multivariable analysis revealed that methylation at CG9, a non-imprinted CpG site within the MEG3 promotor region which contains a CCCTC-binding factor (CTCF)-binding DNA sequence, is an independent prognostic factor for the overall survival of AML patients.\nCONCLUSIONS: The results of our pilot study underscore the importance of the DLK1-MEG3 locus in AML development and progression. We identify CG9 methylation as an independent prognostic factor for AML patient survival, which suggests that distinct miRNA signatures from the DLK1-MEG3 locus could reflect varying degrees of cell stemness and present novel opportunities for personalized therapies in the future. These data provide a foundation for future studies into the role of higher-order chromatin structure at DLK1-MEG3 in AML.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/s13148-019-0643-z", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.4717101", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2498991", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2543644", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1042271", 
            "issn": [
              "1868-7075", 
              "1868-7083"
            ], 
            "name": "Clinical Epigenetics", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "11"
          }
        ], 
        "keywords": [
          "acute myeloid leukemia", 
          "independent prognostic factor", 
          "overall survival", 
          "prognostic factors", 
          "AML patients", 
          "multivariable analysis", 
          "acute myeloid leukemia patients", 
          "better overall survival", 
          "longer overall survival", 
          "shorter overall survival", 
          "myeloid leukemia patients", 
          "patient overall survival", 
          "non-canonical Notch ligand 1", 
          "AML patient survival", 
          "distinct miRNA signatures", 
          "induction therapy", 
          "patient survival", 
          "mononuclear cells", 
          "leukemia patients", 
          "myeloid leukemia", 
          "patient response", 
          "treatment response", 
          "promotor region", 
          "patients", 
          "AML development", 
          "CpG sites", 
          "hematopoietic stem cells", 
          "MEG3 expression", 
          "personalized therapy", 
          "pilot study", 
          "cell stemness", 
          "miRNA signature", 
          "survival", 
          "DLK1-MEG3 locus", 
          "ligand 1", 
          "therapy", 
          "expression of Dlk1", 
          "stem cells", 
          "bisulfite restriction analysis", 
          "progression", 
          "future studies", 
          "MEG3", 
          "critical role", 
          "cells", 
          "factors", 
          "leukemia", 
          "expression", 
          "DLK1", 
          "response", 
          "DNA methylation", 
          "novel opportunities", 
          "methylation results", 
          "methylation", 
          "stemness", 
          "study", 
          "role", 
          "restriction analysis", 
          "present novel opportunities", 
          "methylation upstream", 
          "CCCTC-binding factor", 
          "sites", 
          "differentiation", 
          "evidence", 
          "development", 
          "DLK1-MEG3", 
          "imprinted loci", 
          "analysis", 
          "promotor", 
          "genes", 
          "loci", 
          "maintenance", 
          "results", 
          "region", 
          "amplicons", 
          "addition", 
          "data", 
          "degree", 
          "importance", 
          "future", 
          "chromatin structure", 
          "opportunities", 
          "DNA sequences", 
          "signatures", 
          "upstream", 
          "sequence", 
          "contribution", 
          "foundation", 
          "structure", 
          "higher-order chromatin structure", 
          "delta-like non-canonical Notch ligand 1", 
          "Notch ligand 1", 
          "select CG dinucleotide-containing amplicons", 
          "CG dinucleotide-containing amplicons", 
          "dinucleotide-containing amplicons", 
          "first-round induction therapy", 
          "MEG3 promotor region", 
          "MEG3-DMR CpG site", 
          "CG9", 
          "non-imprinted CpG site", 
          "CG9 methylation", 
          "MEG3 promotor"
        ], 
        "name": "Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival", 
        "pagination": "50", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1112771414"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/s13148-019-0643-z"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "30876483"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/s13148-019-0643-z", 
          "https://app.dimensions.ai/details/publication/pub.1112771414"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-12-01T19:46", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_832.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/s13148-019-0643-z"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13148-019-0643-z'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13148-019-0643-z'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13148-019-0643-z'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13148-019-0643-z'


     

    This table displays all metadata directly associated to this object as RDF triples.

    362 TRIPLES      22 PREDICATES      160 URIs      137 LITERALS      25 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/s13148-019-0643-z schema:about N023ff6e2e28d4ef1b685c7e6bad30ae4
    2 N0d9377dce21c4bd5a9c1d3d479f77e1b
    3 N24461ebd5bc044a9a0c3be8a0ad0f9e1
    4 N36b8ba64c5a245a5aea5cf8ba1680e7f
    5 N393202f8c9cc4fefb5bd274ed671ca77
    6 N3f61b99240b24748b323ff079bd44719
    7 N78c47e16ef874b88b2c6a236947e11d4
    8 N82729f56ee2d4a2dacfa9be3da6170d7
    9 N89cb9614b48d48a7979b709561c38739
    10 N9554f5f1e83848edbc315a13f98286ed
    11 N9826d4d901854b1bb4d0c40324aa3022
    12 Na2951342ff7d408bbd420cc721856dc3
    13 Naf080588ad5145de848bcedb7de6aa02
    14 Nb06dca28725d448ca4a914c56c0a8966
    15 Nc96e61bb19874792a9cde22da2c6ecac
    16 Nd143e2c66a1543a99612ed121de1991a
    17 Ndb0973b3fa6346e7b2dd1272f26ec13c
    18 Nfc1e366307554ad4b314e937c82e0de0
    19 anzsrc-for:11
    20 anzsrc-for:1112
    21 schema:author Ne22856cdfc8f41a990ab37796a1481c4
    22 schema:citation sg:pub.10.1007/s10577-005-1015-4
    23 sg:pub.10.1007/s12015-018-9838-5
    24 sg:pub.10.1038/leu.2009.153
    25 sg:pub.10.1038/leu.2012.111
    26 sg:pub.10.1038/leu.2015.47
    27 sg:pub.10.1038/leu.2017.116
    28 sg:pub.10.1038/leu.2017.148
    29 sg:pub.10.1038/nature02402
    30 sg:pub.10.1038/nature09017
    31 sg:pub.10.1038/nature12303
    32 sg:pub.10.1038/nbt1331
    33 sg:pub.10.1038/ng.2007.56
    34 sg:pub.10.1038/sj.leu.2403832
    35 sg:pub.10.1038/sj.onc.1208637
    36 sg:pub.10.1186/s13148-018-0486-z
    37 schema:datePublished 2019-03-15
    38 schema:datePublishedReg 2019-03-15
    39 schema:description BACKGROUND: The delta-like non-canonical Notch ligand 1 (DLK1)-maternally expressed 3(MEG3) locus (DLK1-MEG3 locus) plays a critical role in the maintenance and differentiation of hematopoietic stem cells. Accumulating evidence implicates the imprinted genes from this locus, DLK1 and MEG3, in the development and progression of acute myeloid leukemia (AML). However, the contribution of this locus to the treatment response of patients and their survival is unknown. METHODS: DNA methylation of select CG dinucleotide-containing amplicons (CpG sites) within the DLK1-MEG3 locus and within differentially methylated regions of other imprinted loci was assessed in the mononuclear cells of 45 AML patients by combined bisulfite restriction analysis. Methylation results were compared with patient response to first-round induction therapy and overall survival. Multivariable analysis was employed to identify independent prognostic factors for patient overall survival in AML. RESULTS: Increased methylation at CpG sites within the MEG3 promotor region was observed in AML patients having longer overall survival. In addition, patients with shorter overall survival had increased expression of DLK1 and MEG3, and methylation at the MEG3-DMR CpG site inversely correlated with MEG3 expression. Multivariable analysis revealed that methylation at CG9, a non-imprinted CpG site within the MEG3 promotor region which contains a CCCTC-binding factor (CTCF)-binding DNA sequence, is an independent prognostic factor for the overall survival of AML patients. CONCLUSIONS: The results of our pilot study underscore the importance of the DLK1-MEG3 locus in AML development and progression. We identify CG9 methylation as an independent prognostic factor for AML patient survival, which suggests that distinct miRNA signatures from the DLK1-MEG3 locus could reflect varying degrees of cell stemness and present novel opportunities for personalized therapies in the future. These data provide a foundation for future studies into the role of higher-order chromatin structure at DLK1-MEG3 in AML.
    40 schema:genre article
    41 schema:inLanguage en
    42 schema:isAccessibleForFree true
    43 schema:isPartOf N2b788efc14c749a3bf6cd3ed7020e9a5
    44 N375d3f486e9746d7891d63dc311e620a
    45 sg:journal.1042271
    46 schema:keywords AML development
    47 AML patient survival
    48 AML patients
    49 CCCTC-binding factor
    50 CG dinucleotide-containing amplicons
    51 CG9
    52 CG9 methylation
    53 CpG sites
    54 DLK1
    55 DLK1-MEG3
    56 DLK1-MEG3 locus
    57 DNA methylation
    58 DNA sequences
    59 MEG3
    60 MEG3 expression
    61 MEG3 promotor
    62 MEG3 promotor region
    63 MEG3-DMR CpG site
    64 Notch ligand 1
    65 acute myeloid leukemia
    66 acute myeloid leukemia patients
    67 addition
    68 amplicons
    69 analysis
    70 better overall survival
    71 bisulfite restriction analysis
    72 cell stemness
    73 cells
    74 chromatin structure
    75 contribution
    76 critical role
    77 data
    78 degree
    79 delta-like non-canonical Notch ligand 1
    80 development
    81 differentiation
    82 dinucleotide-containing amplicons
    83 distinct miRNA signatures
    84 evidence
    85 expression
    86 expression of Dlk1
    87 factors
    88 first-round induction therapy
    89 foundation
    90 future
    91 future studies
    92 genes
    93 hematopoietic stem cells
    94 higher-order chromatin structure
    95 importance
    96 imprinted loci
    97 independent prognostic factor
    98 induction therapy
    99 leukemia
    100 leukemia patients
    101 ligand 1
    102 loci
    103 longer overall survival
    104 maintenance
    105 methylation
    106 methylation results
    107 methylation upstream
    108 miRNA signature
    109 mononuclear cells
    110 multivariable analysis
    111 myeloid leukemia
    112 myeloid leukemia patients
    113 non-canonical Notch ligand 1
    114 non-imprinted CpG site
    115 novel opportunities
    116 opportunities
    117 overall survival
    118 patient overall survival
    119 patient response
    120 patient survival
    121 patients
    122 personalized therapy
    123 pilot study
    124 present novel opportunities
    125 prognostic factors
    126 progression
    127 promotor
    128 promotor region
    129 region
    130 response
    131 restriction analysis
    132 results
    133 role
    134 select CG dinucleotide-containing amplicons
    135 sequence
    136 shorter overall survival
    137 signatures
    138 sites
    139 stem cells
    140 stemness
    141 structure
    142 study
    143 survival
    144 therapy
    145 treatment response
    146 upstream
    147 schema:name Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival
    148 schema:pagination 50
    149 schema:productId N4a94ecb5a7eb483cb478166145c90710
    150 N512f802057274e4db851338dbc854a91
    151 Nf8849715b70243b283c7ecb5319fa89f
    152 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112771414
    153 https://doi.org/10.1186/s13148-019-0643-z
    154 schema:sdDatePublished 2021-12-01T19:46
    155 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    156 schema:sdPublisher Na29f786f2bd34ee2832e8de96d827054
    157 schema:url https://doi.org/10.1186/s13148-019-0643-z
    158 sgo:license sg:explorer/license/
    159 sgo:sdDataset articles
    160 rdf:type schema:ScholarlyArticle
    161 N023ff6e2e28d4ef1b685c7e6bad30ae4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    162 schema:name Gene Expression Regulation, Neoplastic
    163 rdf:type schema:DefinedTerm
    164 N0d9377dce21c4bd5a9c1d3d479f77e1b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Male
    166 rdf:type schema:DefinedTerm
    167 N2189f80bf07f4ab1ab97f2b6ab7d3fcc rdf:first sg:person.01127634326.53
    168 rdf:rest Naba2c42501564163a124d514f215ba2f
    169 N24461ebd5bc044a9a0c3be8a0ad0f9e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    170 schema:name Leukemia, Myeloid, Acute
    171 rdf:type schema:DefinedTerm
    172 N2b788efc14c749a3bf6cd3ed7020e9a5 schema:volumeNumber 11
    173 rdf:type schema:PublicationVolume
    174 N36b8ba64c5a245a5aea5cf8ba1680e7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Genomic Imprinting
    176 rdf:type schema:DefinedTerm
    177 N375d3f486e9746d7891d63dc311e620a schema:issueNumber 1
    178 rdf:type schema:PublicationIssue
    179 N393202f8c9cc4fefb5bd274ed671ca77 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    180 schema:name Sequence Analysis, DNA
    181 rdf:type schema:DefinedTerm
    182 N3f61b99240b24748b323ff079bd44719 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    183 schema:name Young Adult
    184 rdf:type schema:DefinedTerm
    185 N45986316f3664831b666f13ce464511f rdf:first sg:person.0734513303.36
    186 rdf:rest N8b111631296349eda0fd710962e709cf
    187 N4a94ecb5a7eb483cb478166145c90710 schema:name dimensions_id
    188 schema:value pub.1112771414
    189 rdf:type schema:PropertyValue
    190 N512f802057274e4db851338dbc854a91 schema:name doi
    191 schema:value 10.1186/s13148-019-0643-z
    192 rdf:type schema:PropertyValue
    193 N564cc564a5364de2adb5f8cfa3293cd4 rdf:first sg:person.01304531757.79
    194 rdf:rest rdf:nil
    195 N78c47e16ef874b88b2c6a236947e11d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    196 schema:name DNA Methylation
    197 rdf:type schema:DefinedTerm
    198 N82729f56ee2d4a2dacfa9be3da6170d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    199 schema:name Humans
    200 rdf:type schema:DefinedTerm
    201 N88e96ea3e3fa4d6cbc5a4052f36badc1 rdf:first sg:person.01210213422.61
    202 rdf:rest N45986316f3664831b666f13ce464511f
    203 N89cb9614b48d48a7979b709561c38739 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    204 schema:name Female
    205 rdf:type schema:DefinedTerm
    206 N8b111631296349eda0fd710962e709cf rdf:first sg:person.0725226540.08
    207 rdf:rest Nfc8b9a4165a54806918d9d78ded2e357
    208 N9554f5f1e83848edbc315a13f98286ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    209 schema:name Induction Chemotherapy
    210 rdf:type schema:DefinedTerm
    211 N9826d4d901854b1bb4d0c40324aa3022 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    212 schema:name Calcium-Binding Proteins
    213 rdf:type schema:DefinedTerm
    214 Na2951342ff7d408bbd420cc721856dc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    215 schema:name Promoter Regions, Genetic
    216 rdf:type schema:DefinedTerm
    217 Na29f786f2bd34ee2832e8de96d827054 schema:name Springer Nature - SN SciGraph project
    218 rdf:type schema:Organization
    219 Naba2c42501564163a124d514f215ba2f rdf:first sg:person.013444343657.96
    220 rdf:rest N564cc564a5364de2adb5f8cfa3293cd4
    221 Naf080588ad5145de848bcedb7de6aa02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    222 schema:name RNA, Long Noncoding
    223 rdf:type schema:DefinedTerm
    224 Nb06dca28725d448ca4a914c56c0a8966 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    225 schema:name Membrane Proteins
    226 rdf:type schema:DefinedTerm
    227 Nc274dc50484743e7a85a0d9289a7d3e8 schema:affiliation grid-institutes:grid.22254.33
    228 schema:familyName Lewandowski
    229 schema:givenName Krzysztof
    230 rdf:type schema:Person
    231 Nc96e61bb19874792a9cde22da2c6ecac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    232 schema:name Pilot Projects
    233 rdf:type schema:DefinedTerm
    234 Nd143e2c66a1543a99612ed121de1991a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    235 schema:name Survival Analysis
    236 rdf:type schema:DefinedTerm
    237 Ndb0973b3fa6346e7b2dd1272f26ec13c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    238 schema:name Middle Aged
    239 rdf:type schema:DefinedTerm
    240 Ne22856cdfc8f41a990ab37796a1481c4 rdf:first sg:person.01203064236.14
    241 rdf:rest N88e96ea3e3fa4d6cbc5a4052f36badc1
    242 Nf8849715b70243b283c7ecb5319fa89f schema:name pubmed_id
    243 schema:value 30876483
    244 rdf:type schema:PropertyValue
    245 Nfc1e366307554ad4b314e937c82e0de0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    246 schema:name Adult
    247 rdf:type schema:DefinedTerm
    248 Nfc8b9a4165a54806918d9d78ded2e357 rdf:first Nc274dc50484743e7a85a0d9289a7d3e8
    249 rdf:rest N2189f80bf07f4ab1ab97f2b6ab7d3fcc
    250 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    251 schema:name Medical and Health Sciences
    252 rdf:type schema:DefinedTerm
    253 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    254 schema:name Oncology and Carcinogenesis
    255 rdf:type schema:DefinedTerm
    256 sg:grant.2498991 http://pending.schema.org/fundedItem sg:pub.10.1186/s13148-019-0643-z
    257 rdf:type schema:MonetaryGrant
    258 sg:grant.2543644 http://pending.schema.org/fundedItem sg:pub.10.1186/s13148-019-0643-z
    259 rdf:type schema:MonetaryGrant
    260 sg:grant.4717101 http://pending.schema.org/fundedItem sg:pub.10.1186/s13148-019-0643-z
    261 rdf:type schema:MonetaryGrant
    262 sg:journal.1042271 schema:issn 1868-7075
    263 1868-7083
    264 schema:name Clinical Epigenetics
    265 schema:publisher Springer Nature
    266 rdf:type schema:Periodical
    267 sg:person.01127634326.53 schema:affiliation grid-institutes:grid.48324.39
    268 schema:familyName Moniuszko
    269 schema:givenName Marcin
    270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127634326.53
    271 rdf:type schema:Person
    272 sg:person.01203064236.14 schema:affiliation grid-institutes:grid.266623.5
    273 schema:familyName Sellers
    274 schema:givenName Zachariah Payne
    275 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203064236.14
    276 rdf:type schema:Person
    277 sg:person.01210213422.61 schema:affiliation grid-institutes:grid.48324.39
    278 schema:familyName Bolkun
    279 schema:givenName Lukasz
    280 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210213422.61
    281 rdf:type schema:Person
    282 sg:person.01304531757.79 schema:affiliation grid-institutes:grid.266623.5
    283 schema:familyName Schneider
    284 schema:givenName Gabriela
    285 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304531757.79
    286 rdf:type schema:Person
    287 sg:person.013444343657.96 schema:affiliation grid-institutes:grid.13339.3b
    288 schema:familyName Ratajczak
    289 schema:givenName Mariusz Z.
    290 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013444343657.96
    291 rdf:type schema:Person
    292 sg:person.0725226540.08 schema:affiliation grid-institutes:grid.22254.33
    293 schema:familyName Wojtaszewska
    294 schema:givenName Marzena Liliana
    295 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725226540.08
    296 rdf:type schema:Person
    297 sg:person.0734513303.36 schema:affiliation grid-institutes:grid.48324.39
    298 schema:familyName Kloczko
    299 schema:givenName Janusz
    300 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734513303.36
    301 rdf:type schema:Person
    302 sg:pub.10.1007/s10577-005-1015-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002796511
    303 https://doi.org/10.1007/s10577-005-1015-4
    304 rdf:type schema:CreativeWork
    305 sg:pub.10.1007/s12015-018-9838-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105315115
    306 https://doi.org/10.1007/s12015-018-9838-5
    307 rdf:type schema:CreativeWork
    308 sg:pub.10.1038/leu.2009.153 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002488822
    309 https://doi.org/10.1038/leu.2009.153
    310 rdf:type schema:CreativeWork
    311 sg:pub.10.1038/leu.2012.111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049424250
    312 https://doi.org/10.1038/leu.2012.111
    313 rdf:type schema:CreativeWork
    314 sg:pub.10.1038/leu.2015.47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014631957
    315 https://doi.org/10.1038/leu.2015.47
    316 rdf:type schema:CreativeWork
    317 sg:pub.10.1038/leu.2017.116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084752577
    318 https://doi.org/10.1038/leu.2017.116
    319 rdf:type schema:CreativeWork
    320 sg:pub.10.1038/leu.2017.148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085414856
    321 https://doi.org/10.1038/leu.2017.148
    322 rdf:type schema:CreativeWork
    323 sg:pub.10.1038/nature02402 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028269094
    324 https://doi.org/10.1038/nature02402
    325 rdf:type schema:CreativeWork
    326 sg:pub.10.1038/nature09017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050347178
    327 https://doi.org/10.1038/nature09017
    328 rdf:type schema:CreativeWork
    329 sg:pub.10.1038/nature12303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028161095
    330 https://doi.org/10.1038/nature12303
    331 rdf:type schema:CreativeWork
    332 sg:pub.10.1038/nbt1331 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012172214
    333 https://doi.org/10.1038/nbt1331
    334 rdf:type schema:CreativeWork
    335 sg:pub.10.1038/ng.2007.56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000021875
    336 https://doi.org/10.1038/ng.2007.56
    337 rdf:type schema:CreativeWork
    338 sg:pub.10.1038/sj.leu.2403832 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049538565
    339 https://doi.org/10.1038/sj.leu.2403832
    340 rdf:type schema:CreativeWork
    341 sg:pub.10.1038/sj.onc.1208637 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011733790
    342 https://doi.org/10.1038/sj.onc.1208637
    343 rdf:type schema:CreativeWork
    344 sg:pub.10.1186/s13148-018-0486-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1103148817
    345 https://doi.org/10.1186/s13148-018-0486-z
    346 rdf:type schema:CreativeWork
    347 grid-institutes:grid.13339.3b schema:alternateName Department of Regenerative Medicine, Medical University of Warsaw, Warsaw, Poland
    348 schema:name Department of Regenerative Medicine, Medical University of Warsaw, Warsaw, Poland
    349 Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY USA
    350 rdf:type schema:Organization
    351 grid-institutes:grid.22254.33 schema:alternateName Department of Hematology and Bone Marrow Transplantation, University of Medical Sciences, Poznań, Poland
    352 schema:name Department of Hematology and Bone Marrow Transplantation, University of Medical Sciences, Poznań, Poland
    353 rdf:type schema:Organization
    354 grid-institutes:grid.266623.5 schema:alternateName Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY USA
    355 schema:name Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY USA
    356 rdf:type schema:Organization
    357 grid-institutes:grid.48324.39 schema:alternateName Department of Hematology, Medical University of Bialystok, Bialystok, Poland
    358 Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland
    359 schema:name Department of Allergology, Medical University of Bialystok, Bialystok, Poland
    360 Department of Hematology, Medical University of Bialystok, Bialystok, Poland
    361 Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland
    362 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...